2.07
前日終値:
$2.07
開ける:
$2.08
24時間の取引高:
267.13K
Relative Volume:
1.01
時価総額:
$35.86M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.48%
1か月 パフォーマンス:
+17.61%
6か月 パフォーマンス:
-46.92%
1年 パフォーマンス:
-36.11%
Mural Oncology Plc Stock (MURA) Company Profile
MURA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MURA
Mural Oncology Plc
|
2.07 | 35.86M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
Citadel Group discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.55% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.73% stake in Mural Oncology - Investing.com
Trium Capital discloses 10.55% stake in Mural Oncology - Investing.com
Bull Run: Can LDTCW keep up with sector leadersVolume Spike & Real-Time Volume Trigger Notifications - خودرو بانک
Resistance Check: Why is RMBI stock going down2025 Growth vs Value & Comprehensive Market Scan Insights - خودرو بانک
Market Outlook: Can Integra Resources Corp reach all time highs this yearQuarterly Growth Report & Growth Focused Investment Plans - خودرو بانک
Fundamentals Check: Is Mural Oncology plc a defensive stockQuarterly Performance Summary & Weekly Stock Performance Updates - خودرو بانک
Sentiment Recap: Is Mural Oncology plc stock influenced by commodity prices2025 Stock Rankings & Safe Entry Point Identification - خودرو بانک
Big Picture: What dividend growth rate does Mural Oncology plc offer2025 Geopolitical Influence & AI Driven Price Forecasts - خودرو بانک
Citadel Group discloses 1.75% stake in Mural Oncology - Investing.com India
Dow Update: Can OILU reach all time highs this yearCPI Data & Low Risk High Win Rate Picks - خودرو بانک
Bull Bear: Is Mural Oncology plc a defensive stock2025 Macro Impact & AI Forecast Swing Trade Picks - خودرو بانک
Gains Recap: Can Mural Oncology plc benefit from deglobalizationJuly 2025 Setups & Low Risk Investment Opportunities - خودرو بانک
Citadel Group discloses 1.76% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.76% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - MarketScreener
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders - GlobeNewswire Inc.
Citadel discloses 1.73% stake in Mural Oncology - Investing.com
Citadel discloses 1.73% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology By Investing.com - Investing.com Australia
Trium Capital discloses 10.52% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology By Investing.com - Investing.com Australia
BlackRock discloses 1.61% stake in Mural Oncology By Investing.com - Investing.com Canada
Is Mural Oncology plc stock a good dividend stockWeekly Trend Report & AI Driven Price Predictions - Lancaster City Council
BlackRock discloses 1.61% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.74% stake in Mural Oncology - Investing.com
Mural Oncology plc Stock Recovery Path — Analyst Breakdown2025 Macro Impact & Consistent Return Investment Signals - beatles.ru
Is Mural Oncology plc showing insider buyingWeekly Market Report & Daily Profit Maximizing Tips - beatles.ru
Pattern Scan Adds Mural Oncology plc to Watchlist2025 Top Gainers & Verified Momentum Stock Ideas - beatles.ru
Is Mural Oncology plc’s ROE strong enoughJuly 2025 Gainers & Daily Momentum Trading Reports - 강소기업뉴스
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com Nigeria
Visual analytics tools that track Mural Oncology plc performanceWeekly Risk Report & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Mural Oncology plc2025 Market WrapUp & Safe Capital Preservation Plans - Newser
What to expect from Mural Oncology plc in the next 30 daysGold Moves & Fast Exit and Entry Strategy Plans - Newser
Sector ETF performance correlation with Mural Oncology plcPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Heatmap analysis for Mural Oncology plc and competitorsQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Is Mural Oncology plc vulnerable to short sellersRisk Management & Weekly Hot Stock Watchlists - خودرو بانک
Citadel Group discloses 1.68% stake in Mural Oncology By Investing.com - Investing.com Canada
Will Mural Oncology plc benefit from rising consumer demand2025 Major Catalysts & Advanced Swing Trade Entry Plans - خودرو بانک
Can Mural Oncology plc be the next market leaderEarnings Trend Report & Weekly Stock Performance Updates - خودرو بانک
Is it time to cut losses on Mural Oncology plc2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Is Mural Oncology plc reversing from oversold territory2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
What institutional flow reveals about Mural Oncology plc2025 Year in Review & Smart Allocation Stock Reports - Newser
Is Mural Oncology plc exposed to currency risksGap Up & Low Risk Profit Maximizing Plans - خودرو بانک
BlackRock discloses 1.62% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.65% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.68% stake in Mural Oncology - Investing.com India
Boston M&A in August Mural Oncology, UWill and scPharmaceuticals - The Business Journals
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Mural Oncology Plc (MURA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
大文字化:
|
ボリューム (24 時間):